The efficacy of aspirin to inhibit platelet aggregation in patients hospitalised with a severe infection: a multicentre, open-label, randomised controlled trial

Patients with severe infection have an increased risk of cardiovascular events. A possible underlying mechanism is inflammation-induced platelet aggregation. We investigated whether hyperaggregation occurs during infection, and whether aspirin inhibits this. In this multicentre, open-label, randomis...

Descripción completa

Detalles Bibliográficos
Autores principales: van Zijverden, Lieve Mees, Schutte, Moya Henriëtte, Madsen, Milou Cecilia, Bonten, Tobias Nicolaas, Smulders, Yvo Michiel, Wiepjes, Chantal Maria, van Diemen, Jeske Joanna Katarina, Thijs, Abel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10250844/
https://www.ncbi.nlm.nih.gov/pubmed/37294478
http://dx.doi.org/10.1007/s10238-023-01101-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10250844/
https://www.ncbi.nlm.nih.gov/pubmed/37294478
http://dx.doi.org/10.1007/s10238-023-01101-5

Ejemplares similares